Globe Life (NYSE:GL) Updates FY 2025 Earnings Guidance

Globe Life (NYSE:GL) updated its FY 2025 earnings guidance on Wednesday. The company provided EPS guidance of 13.200-13.900 for the period, compared to the consensus EPS estimate of 13.250. The company issued revenue guidance of -. Globe Life also updated its FY 2024 guidance to 12.200-12.400 EPS.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on the stock. Truist Financial upped their price objective on shares of Globe Life from $80.00 to $90.00 and gave the company a “hold” rating in a research note on Friday, July 26th. Piper Sandler upped their price target on shares of Globe Life from $106.00 to $118.00 and gave the company an “overweight” rating in a research report on Wednesday, October 2nd. Wells Fargo & Company lifted their price objective on Globe Life from $108.00 to $117.00 and gave the stock an “overweight” rating in a research report on Thursday, October 10th. Keefe, Bruyette & Woods restated an “outperform” rating and set a $118.00 target price (up previously from $110.00) on shares of Globe Life in a research report on Wednesday, July 31st. Finally, Raymond James lifted their target price on Globe Life from $160.00 to $188.00 and gave the stock a “strong-buy” rating in a report on Tuesday, October 15th. Five equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $117.40.

Globe Life Stock Down 0.2 %

NYSE GL traded down $0.21 during mid-day trading on Wednesday, hitting $110.86. The company’s stock had a trading volume of 653,718 shares, compared to its average volume of 1,601,265. The company has a current ratio of 0.05, a quick ratio of 0.05 and a debt-to-equity ratio of 0.31. The company’s 50 day simple moving average is $104.60 and its 200 day simple moving average is $90.63. Globe Life has a twelve month low of $38.95 and a twelve month high of $132.00. The firm has a market capitalization of $9.98 billion, a price-to-earnings ratio of 10.60 and a beta of 0.81.

Globe Life (NYSE:GL) last posted its earnings results on Wednesday, July 24th. The company reported $2.97 EPS for the quarter, topping the consensus estimate of $2.90 by $0.07. Globe Life had a net margin of 18.47% and a return on equity of 21.93%. The company had revenue of $1.44 billion during the quarter, compared to the consensus estimate of $1.45 billion. During the same period in the previous year, the firm posted $2.61 earnings per share. The firm’s revenue for the quarter was up 8.6% on a year-over-year basis. Analysts anticipate that Globe Life will post 11.93 earnings per share for the current year.

Globe Life Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 1st. Shareholders of record on Friday, October 4th will be issued a dividend of $0.24 per share. This represents a $0.96 dividend on an annualized basis and a yield of 0.87%. The ex-dividend date is Friday, October 4th. Globe Life’s dividend payout ratio is currently 9.17%.

Insider Activity

In other news, Director Mary E. Thigpen acquired 3,000 shares of the business’s stock in a transaction on Friday, July 26th. The shares were purchased at an average cost of $90.20 per share, with a total value of $270,600.00. Following the acquisition, the director now directly owns 15,605 shares of the company’s stock, valued at $1,407,571. The trade was a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 1.51% of the company’s stock.

Globe Life Company Profile

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.